The Fa-PCD/pCKb11/iPD-L1 treatment had the strongest anti-vascular effect with the least amount of microvessels, as well as the most potent anti-tumor proliferation ability with the lowest percentage of Ki-67 positive cells. The gene discussed is MKI67; the disease is neoplasm.